 Theresa Medina
Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 6 | 2023 | 651 | 0.670 |
Why?
| | Sentinel Lymph Node | 2 | 2021 | 38 | 0.350 |
Why?
| | Skin Neoplasms | 2 | 2021 | 761 | 0.220 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2023 | 56 | 0.200 |
Why?
| | Neoplasms, Second Primary | 1 | 2023 | 91 | 0.200 |
Why?
| | Nomograms | 1 | 2019 | 42 | 0.170 |
Why?
| | Neurofibromin 1 | 1 | 2017 | 22 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2017 | 63 | 0.140 |
Why?
| | RNA Splicing Factors | 1 | 2017 | 50 | 0.140 |
Why?
| | Immunotherapy | 1 | 2020 | 479 | 0.140 |
Why?
| | Mucous Membrane | 1 | 2017 | 109 | 0.140 |
Why?
| | Exome | 1 | 2017 | 202 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 178 | 0.130 |
Why?
| | Phosphoproteins | 1 | 2017 | 304 | 0.120 |
Why?
| | Decision Making | 1 | 2019 | 791 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1048 | 0.090 |
Why?
| | Risk Assessment | 1 | 2019 | 2987 | 0.090 |
Why?
| | Sentinel Lymph Node Biopsy | 2 | 2021 | 98 | 0.090 |
Why?
| | Leiomyoma | 1 | 2008 | 45 | 0.080 |
Why?
| | Uterine Neoplasms | 1 | 2008 | 73 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 704 | 0.070 |
Why?
| | Mutation | 1 | 2017 | 3364 | 0.070 |
Why?
| | Tretinoin | 1 | 2023 | 124 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1536 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2021 | 141 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2019 | 4440 | 0.040 |
Why?
| | Middle Aged | 4 | 2021 | 26998 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2017 | 339 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1178 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 639 | 0.030 |
Why?
| | Humans | 7 | 2023 | 115589 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1361 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1138 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2017 | 443 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2021 | 12608 | 0.030 |
Why?
| | Mice | 2 | 2020 | 15052 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2020 | 3580 | 0.020 |
Why?
| | Aged | 2 | 2019 | 19250 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3022 | 0.020 |
Why?
| | Female | 4 | 2019 | 59913 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3339 | 0.020 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 80 | 0.020 |
Why?
| | Myometrium | 1 | 2008 | 35 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2008 | 258 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 157 | 0.020 |
Why?
| | Animals | 2 | 2020 | 32102 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 514 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 930 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6417 | 0.020 |
Why?
| | Base Sequence | 1 | 2008 | 2114 | 0.010 |
Why?
| | Male | 2 | 2019 | 55949 | 0.010 |
Why?
| | Adult | 1 | 2017 | 30719 | 0.010 |
Why?
|
|
Medina's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|